StatPearls, LLC

  • Dysmenorrhea
  • Fever
  • Ibuprofen
  • Osteoarthritis

Ibuprofen

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to manage various conditions, including inflammatory diseases, rheumatoid disorders, mild to moderate pain, fever, dysmenorrhea, and osteoarthritis. This drug is available over-the-counter and in prescription strength. This activity reviews ibuprofen’s mechanism of action, adverse event profiles, dosing considerations, pharmacokinetics, contraindications, box warnings, and monitoring protocols, which are critical areas of focus. Understanding ibuprofen’s pharmacology enables healthcare professionals to optimize dosage regimens and minimize potential adverse effects. This educational activity also discusses the role of the interprofessional healthcare team in providing quality patient care using ibuprofen therapy, improving patient outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 2 creditsAMA PRA Category 1 Credit™Up to 2 creditsNursingUp to 2 creditsPharmacyUp to 2 credits

MOC types

ABS — Accredited CMEUp to 2 pointsABOS — Accredited CMEUp to 2 pointsABPATH — Lifelong LearningUp to 2 pointsABA — Lifelong LearningUp to 2 pointsABTS — Accredited CMEUp to 2 pointsABIM — Medical KnowledgeUp to 2 pointsABS — Self-AssessmentUp to 2 pointsABP — Lifelong Learning and Self-AssessmentUp to 2 pointsABOHNS — Self-AssessmentUp to 2 pointsABTS — Self-AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 15 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left